Tivozanib + Enzalutamide in Adv Prostate Cancer
Massachusetts General Hospital
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
University of Wisconsin, Madison
Incyte Corporation
National Cancer Institute (NCI)
Tempus AI
M.D. Anderson Cancer Center
Duke University
Incyte Corporation
Incyte Corporation
Incyte Corporation
Trishula Therapeutics, Inc.
Eli Lilly and Company
University of Washington
NRG Oncology
Astellas Pharma Inc
University of Washington
Elevation Oncology
Indiana University
Incyte Corporation
University of Washington
Daiichi Sankyo
Astellas Pharma Inc
Pfizer
Pfizer
University of Michigan Rogel Cancer Center
Eli Lilly and Company
NextCure, Inc.
Icahn School of Medicine at Mount Sinai
Tavanta Therapeutics
Processa Pharmaceuticals
Rutgers, The State University of New Jersey
pharmaand GmbH
Columbia University
Fred Hutchinson Cancer Center
Nektar Therapeutics
Nektar Therapeutics
Herlev Hospital
Alliance for Clinical Trials in Oncology
University of California, San Francisco
Mendus
Bristol-Myers Squibb
Bristol-Myers Squibb
Pfizer
SWOG Cancer Research Network
M.D. Anderson Cancer Center
University of Texas Southwestern Medical Center
Novartis
Bayer